🇺🇸 FDA
Patent

US 7220757

Compositions and methods for topical administration of 2-NH-heteroarylimidazoles

granted A61KA61K31/4164A61K31/44

Quick answer

US patent 7220757 (Compositions and methods for topical administration of 2-NH-heteroarylimidazoles) held by Replidyne, Inc. expires Mon May 17 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Replidyne, Inc.
Grant date
Tue May 22 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 17 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/4164, A61K31/44, A61P, A61P31/04